U.S. federal trademark · Serial No. 79235070 · Reg. No. 5635338
Products for medical use, namely, pharmaceutical products for use in oncology, especially oligonucleotides, more particularly in the form of double-stranded DNA acting as a decoy or false signal for proteins, especially enzymes, involved in tumor growth and/or tumor escape, more particularly DNA binding proteins and especially tumor cell DNA repair proteins for treating solid and/or liquid cancers
Scientific, medical and pharmaceutical research for the research and identification of new pharmaceutical products limited to these oligonucleotides from a proprietary technology platform or chemo-library; pharmaceutical research and development limited to products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory research limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory analysis limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.